Description
Prosaptide TX14(A) is a peptide fragment of the neurotrophic factor prosaposin and an agonist of GPR37L1 and GPR37.1 It activates ERK signaling in HEK293T cells expressing GPR37L1 or GPR37 (EC50s = 5 and 7 nM, respectively) and inhibits forskolin-induced cAMP production in the same cells. Prosaptide TX14(A) (100 nM) protects primary mouse astrocytes from hydrogen peroxide-induced cell death. It reduces allodynia in a variety of rat peripheral pain models, including models of diabetic neuropathy and sciatic nerve hemiligation when administered at a dose of 4 mg/kg, as well as prevents paw allodynia induced by formalin at 1 mg/kg.2WARNING This product is not for human or veterinary use.
References
[1] REBECCA C MEYER. GPR37 and GPR37L1 are receptors for the neuroprotective and glioprotective factors prosaptide and prosaposin.[J]. Proceedings of the National Academy of Sciences of the United States of America, 2013, 110 23: 9529-9534. DOI:
10.1073/pnas.1219004110[2] CORINNE G. JOLIVALT . Therapeutic efficacy of prosaposin-derived peptide on different models of allodynia[J]. PAIN®, 2006, 121 1: Pages 14-21. DOI:
10.1016/j.pain.2005.11.013